United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 4 minute read Pharma Industry News FDA approves EMBLAVEO to combat complicated intra-abdominal infections with limited treatment options The U.S. Food and Drug Administration (FDA) has granted approval for EMBLAVEO (aztreonam and avibactam), marking a significant… byPallavi MadhirajuFebruary 9, 2025